Xiamen Amoytop Biotech Co. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RT3
  • SHG: 688278
CNY
51.40
-1.7 (-3.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,038.77
797.79
1,216.02
968.93
837.27
669.90
862.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,038.77
797.79
1,216.02
968.93
837.27
669.90
862.46
Raw Material Cost
136.84
101.97
94.63
97.67
65.31
51.20
57.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.76
0.69
0.66
0.38
0.26
0.12
0.10
Selling and Distribution Expenses
426.43
411.61
558.99
499.22
390.27
343.32
424.20
Other Expenses
9.19
8.34
9.83
9.44
10.49
6.37
9.93
Total Expenditure (Excl Depreciation)
656.90
597.70
752.60
691.71
560.72
458.36
581.51
Operating Profit (PBDIT) excl Other Income
381.9
200.10000000000002
463.40000000000003
277.2
276.6
211.5
281
Other Income
-16.75
-10.22
-13.51
-17.52
-5.59
-2.24
8.96
Operating Profit (PBDIT)
397.88
225.90
489.14
301.11
293.36
235.88
310.54
Interest
1.76
0.69
0.66
0.38
0.26
0.12
0.10
Exceptional Items
0.51
0.00
2.38
0.48
0.55
0.04
-0.41
Gross Profit (PBDT)
901.93
695.82
1,121.39
871.26
771.96
618.69
804.60
Depreciation
46.18
46.18
46.48
46.48
26.59
26.59
24.76
Profit Before Tax
350.45
179.04
444.38
254.73
267.06
209.22
285.27
Tax
38.41
14.55
79.26
16.50
21.29
27.09
11.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
312.03
164.49
365.11
238.23
245.77
182.13
273.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
312.03
164.49
365.11
238.23
245.77
182.13
273.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
312.03
164.49
365.11
238.23
245.77
182.13
273.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,103.80
3,630.39
3,449.58
3,009.26
2,755.39
2,749.28
2,553.32
Earnings per share (EPS)
0.76
0.4
0.88
0.59
0.6
0.45
0.67
Diluted Earnings per share
0.76
0.4
0.88
0.59
0.6
0.45
0.67
Operating Profit Margin (Excl OI)
35.47%
23.81%
37.51%
28.09%
32.53%
31.58%
32.1%
Gross Profit Margin
38.18%
28.23%
40.37%
31.09%
35.07%
35.2%
35.95%
PAT Margin
30.04%
20.62%
30.03%
24.59%
29.35%
27.19%
31.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 30.21% vs -34.39% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 89.67% vs -54.94% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 75.60% vs -53.03% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 157.14% vs 0.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Xiamen Amoytop Biotech Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,038.77
0
1,038.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,038.77
0
1,038.77
Raw Material Cost
136.84
0
136.84
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.76
0
1.76
Selling and Distribution Expenses
426.43
0
426.43
Other Expenses
9.19
0.00
9.19
Total Expenditure (Excl Depreciation)
656.90
0
656.90
Operating Profit (PBDIT) excl Other Income
381.87
0.00
381.87
Other Income
-16.75
0
-16.75
Operating Profit (PBDIT)
397.88
0
397.88
Interest
1.76
0
1.76
Exceptional Items
0.51
0
0.51
Gross Profit (PBDT)
901.93
0
901.93
Depreciation
46.18
0
46.18
Profit Before Tax
350.45
0
350.45
Tax
38.41
0
38.41
Provisions and contingencies
0
0
0.00
Profit After Tax
312.03
0
312.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
312.03
0
312.03
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
312.03
0
312.03
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,103.80
0
3,103.80
Earnings per share (EPS)
0.76
0
0.76
Diluted Earnings per share
0.76
0
0.76
Operating Profit Margin (Excl OI)
35.47%
0%
0.00
35.47%
Gross Profit Margin
38.18%
0%
0.00
38.18%
PAT Margin
30.04%
0%
0.00
30.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 103.88 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 30.21% vs -34.39% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 24.07% vs 29.91% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 31.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 89.67% vs -54.94% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 26.93% vs 40.06% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.46 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 75.60% vs -53.03% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 38.71% vs 30.81% in Jun 2025

Quarterly - Interest
Interest 0.18 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 157.14% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 500.00% vs 200.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.47%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading